Hormone therapyFDA-approvedAdjuvant
Aromasin (Exemestane)
Generic name: exemestane
How it works
Blocks the production of estrogen in the body, which can fuel the growth of hormone receptor-positive breast cancer cells.
Cancer types
Breast Cancer— Hormone receptor-positive
Efficacy
Studies show that patients who received exemestane after surgery had a lower risk of recurrence and longer overall survival compared to those who received tamoxifen.
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Elacestrant and Exemestane for Advanced Breast Cancer | Breast Cancer | phase-2 | — | Source → |
| Exemestane and Entinostat in Treating Hormone Receptor-Positive Breast Cancer | Breast Cancer | phase-3 | — | Source → |
| New Combination Therapy Shows Promise in Treating Triple-Negative Breast Cancer | Breast Cancer | lab-study | The combination of Olaparib and Exemestane was able to achieve enhanced tumor growth inhibition in a murine xenograft model, greater than either drug employed as a single agent. | Source → |
| Researchers Improve Cancer-Fighting Nanoparticles | Breast Cancer | lab-study | The optimized nanoparticles induced cytotoxicity in MCF-7 cell lines with an IC50 value of 21.46 µg/mL. | Source → |
| Cost-Effectiveness of Breast Cancer Treatment in China | Breast Cancer | phase-3 | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.